Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma

Glioblastoma multiforme (GBM) is the most aggressive primary central nervous system malignant tumor. The median survival of GBM patients is 12–15 months, and the 5 years survival rate is less than 5%. More novel molecular biomarkers are still urgently required to elucidate the mechanisms or improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Wen, Tang, Guihua, Zhou, Quanwei, Cao, Yudong, Li, Haixia, Fu, Xianyong, Wu, Zhaoping, Jiang, Xingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509566/
https://www.ncbi.nlm.nih.gov/pubmed/31130992
http://dx.doi.org/10.3389/fgene.2019.00419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509566/
https://www.ncbi.nlm.nih.gov/pubmed/31130992
http://dx.doi.org/10.3389/fgene.2019.00419

Ejemplares similares